As already suggested (Jiao et al. 2017), ghrelin neuroprotective and neurogenic roles may be usefully exploited in the development of therapeutic strategies for the treatment of neurodegenerative diseases. The gene discussed is GHRL; the disease is neurodegenerative disease.